Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells.

Hishikawa D, Hashidate T, Shimizu T, Shindou H. · 2014

Read Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. by Hishikawa D, Hashidate T, Shimizu T, Shindou H. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3995458.txt.

Introduction

Daisuke Hishikawa, Tomomi Hashidate, Takao Shimizu, and Hideo Shindou review how cell membranes gain their wide mix of fats, in the Journal of Lipid Research in 2014. Membranes are built largely from a fat family called glycerophospholipids. Each carries a head part and two tail chains, and the pairings vary a lot by cell type and by membrane layer.

Cells first build these fats by a direct route, then reshape the tails in a second, remodelling route. Two enzyme groups do the reshaping, cutting tails off and fitting new ones on. The cycle creates much of the membrane's diversity and also yields signal fats that carry messages in the body. Carrier proteins that move set fats to set places add a further layer of order. The review sums up recent gains in grasping how this mix is built and kept.

Catalog record

CREATORHishikawa D, Hashidate T, Shimizu T, Shindou H.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3995458

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells By Daisuke Hishikawa, Tomomi Hashidate, Takao Shimizu, Hideo Shindou Published in: Journal of Lipid Research DOI: 10.1194/jlr.R046094 ABSTRACT Abstract Cellular membranes are composed of numerous kinds of glycerophospholipids with different combinations of polar heads at the sn-3 position and acyl moieties at the sn-1 and sn-2 positions, respectively. The glycerophospholipid compositions of different cell types, organelles, and inner/outer plasma membrane leaflets are quite diverse. The acyl moieties of glycerophospholipids synthesized in the de novo pathway are subsequently remodeled by the action of phospholipases and lysophospholipid acyltransferases. This remodeling cycle contributes to the generation of membrane glycerophospholipid diversity and the production of lipid mediators such as fatty acid derivatives and lysophospholipids. Furthermore, specific glycerophospholipid transporters are also important to organize a unique glycerophospholipid composition in each organelle. Recent progress in this field contributes to understanding how and why membrane glycerophospholipid diversity is organized and maintained. Keywords: lysophospholipid acyltransferase, membrane biology, phospholipid metabolism One of the major components of cellular membranes is a class of molecules known as glycerophospholipids, which are synthesized from glycerol-3-phosphate (G3P) in a de novo pathway that initially produces phosphatidic acid (PA) and diacylglycerol (DAG) or cytidine diphosphate-DAG (CDP-DAG) (1–3). Via the de novo pathway, various types of glycerophospholipids with different polar heads at the sn-3 position in the glycerol backbone, such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylglycerol (PG), and cardiolipin (CL) are generated (4, 5). Subsequently, glycerophospholipid acyl chains are remodeled by the orchestrated reactions of phospholipase As (PLAs), acyl-CoA synthases, transacylases, and lysophospholipid acyltransferases (LPLATs) (5–9). This glycerophospholipid remodeling (also called Lands’ cycle) was originally described in 1958 and is involved in the generation of a large variety of cellular glycerophospholipids (Fig. 1) (10, 11). Thus far, investigations of glycerophospholipid remodeling have mainly focused on PLAs, especially in the production of lipid mediators (6–8). However, in recent years, various LPLATs have been identified from the 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) and membrane bound O-acyltransferase (MBOAT) families (Table 1). Although studies with tissue homogenates initially suggested that each LPLAT recognizes a specific substrate, isolated LPLATs have shown promiscuous substrate specificities (5, 9, 12). Because the acyl composition of membrane glycerophospholipids is known to affect not only the production of lipid mediators but also membrane properties, characterizing these LPLATs will reveal the biological importance of membrane glycerophospholipid diversity. [Figure: Biosynthetic pathways of glycerophospholipids. Upper panel shows the de novo synthesis (green lines) and the fatty acid remodeling (magenta lines) of glycerophospholipids. LPLATs involved in each reacylation of the lysophospholipids are indicated. Lower panel shows an example of the fatty acid remodeling of PC. In this reaction, PLA2s release fatty acid (arachidonic acid) from the sn-2 position of PC, while LPCATs catalyze the reacylation at the sn-2 position of LPC using acyl-CoA (arachidonoyl-CoA). The details are discussed in the text. PGP, phosphatidylglycerolphosphate.] [Table: Summary of characteristics of LPLATs] In mammalian cells, glycerophospholipid composition differs among cell types, organelles, and inner/outer membranes, and these differences are known to play important roles in various cellular functions including signal transduction, vesicle trafficking, and membrane fluidity (4). Recently, several molecules involved in phospholipid transport between membranes and in phospholipid scrambling in plasma membranes have been identified. These factors are also important for constructing the specific composition of local membranes. In this review, we summarize and discuss the biological importance of the variety of membrane glycerophospholipids generated via glycerophospholipid remodeling by LPLATs. GENERATION OF PUFA-CONTAINING GLYCEROPHOSPHOLIPIDS Glycerophospholipid remodeling by the concerted action of PLAs and LPLATs is important for the production of PUFA-containing glycerophospholipids (8). Glycerophospholipids containing PUFAs, such as arachidonic acid, linoleic acid, EPA, and DHA, are known as major sources of fatty acid-derived lipid mediators and endocannabinoids (8, 13–15). Although numerous studies have shown the importance of PLAs in producing lipid mediators, the involvement of LPLATs in lipid mediator production is poorly understood (6, 7). At present, lyso-PC (LPC) acyltransferase (LPCAT)2, LPCAT3, lyso-PI (LPI) acyltransferase (LPIAT)1, and lyso-PA (LPA) acyltransferase (LPAAT)3 are reported to incorporate PUFAs into lysophospholipids with different acceptor preferences (16–20). LPCAT3 is ubiquitously expressed, especially in liver, testis, kidney, pancreas, and adipose tissue (17, 18). Expression of LPCAT3 mRNA is controlled by PPARα and liver X receptors, and is induced during adipogenesis (21, 22). Knockdown of LPCAT3 by siRNA reduces arachidonic acid incorporation into PC and production of eicosanoids (23). Similar results were obtained from the treatment of thimerosal, a LPLAT inhibitor, and triacsin C, an acyl-CoA synthetase inhibitor (24–28). These reports suggested that the control of arachidonic acid pools in membrane glycerophospholipids is important for the eicosanoid production. Furthermore, it has been reported that induction of LPCAT3 ameliorates saturated free fatty acid-induced endoplasmic reticulum (ER) stress in vitro (29). Using liver-specific LPCAT3 overexpression and knockdown mice, the study demonstrated that LPCAT3 regulates hepatic inflammatory cytokine levels and inflammation. Although the exact mechanism is unclear, the authors suggest that LPCAT3 may control inflammation by altering the fatty acid composition of PC. Although LPCAT2 and LPCAT3 can produce arachidonic acid-containing PC, the substrate preference and expression pattern for each differs. While LPCAT3 prefers 1-acyl LPC as an acyl acceptor, LPCAT2 utilizes both 1-acyl LPC and 1-alkyl LPC (16–18). LPCAT2 is highly expressed in inflammatory cells such as macrophages and neutrophils, which contain ether-phospholipids, and LPCAT2 is believed to contribute to the production of lipid mediators in these cells (16). Induction of LPCAT2 has been observed in three scenarios: i) in macrophages by lipopolysaccharide and CpG oligodeoxynucleotide 1826 stimulation; ii) in the spinal cords of mice with experimental allergic encephalomyelitis; and iii) in mice with peripheral nerve injury (16, 30, 31). These observations support the hypothesis that LPCAT2 may be involved in lipid mediator production under inflammatory conditions. In addition to LPCAT activity, LPCAT2 and LPCAT1 also possess lyso-platelet-activating factor (PAF) acetyltransferase (lysoPAFAT) activity for the production of PAF (16, 32). It has been reported that LPCAT2, but not LPCAT1, is activated by phosphorylation at Ser34 by lipopolysaccharide stimulation for 30 min (33). The biological importance of the dual activities in PAF and PAF-precursor glycerophospholipid production remains to be elucidated. In general, it is thought that PUFAs are mainly incorporated into glycerophospholipids in the remodeling pathway. However, DHA-containing glycerophospholipids are synthesized in the remodeling pathway as well as in the de novo pathway, because CDP-ethanolamine:DAG ethanolamine transferase and PE-N-methyltransferase prefer DHA-containing DAG and PE, respectively, in rat liver microsomes (34–36). In fact, LPAAT3 can produce DHA-containing PA, and LPAAT3 may contribute to the production of DHA-containing glycerophospholipids in the de novo pathway. Overexpression of LPAAT3 in HeLa cells inhibits Golgi tubule formation and protein trafficking (37). Although the mechanism underlying this is unclear, it is possible that the products of LPAAT3 (PUFA-containing PAs) may affect membrane properties. Because PUFAs are reported to increase membrane fluidity, these enzymes may be important not only for lipid mediator production, but also for cellular functions, such as signal transduction and stabilization of proteins, by controlling the biophysical properties of the membrane (38). FUNCTIONS OF DISATURATED GLYCEROPHOSPHOLIPIDS Pulmonary surfactant is produced in alveolar type II (ATII) cells and is secreted into the alveolar space to prevent collapse (39). Pulmonary surfactant is composed of lipids (∼90%), mainly dipalmitoyl-PC (DPPC), and associated

Read the complete text